Elucidation of Potential Inhibitor Compounds from Zingiber officinale against Migraine Headache

• Authors: Adindu Chinonso Blessing , Kalu Georgiana Ijeoma
• Languages of publication: EN

Abstracts

EN

Migraine is a type of headache that generates a pulsing sensation oftentimes on one side of the head. Zingiber officinale (ginger) is a plant material that is used as spice in foods; it has proven to have many health benefits such as reducing nausea and vomiting, inflammation and migraine headache. Herein, we investigate the migraine headache inhibiting ability of the ethanol extract of Zingiber officinale. Molecular docking approach was used to study the ligand-target interactions to identify the compounds with low docking scores, density functional theory calculations was used to estimate the electronic properties of some of the molecules and absorption distribution metabolism elimination and toxicity (ADMET) screening was performed to identify compounds with good pharmacokinetics, and pharmacodynamics properties. Estra-1,3,5(10)-trien-17.beta.-ol showed the best binding scores of -6.8 and -8.8 1Kcal〖mol〗^(-1) in calcitonin gene-related peptide (CGRP) receptor (PDB:3n7r) and human NK1 tachykinin receptor (PDB:6e59) respectively, very close to the control drug Telcagepant which gave the lowest binding scores for the two migraine headache proteins studied -10.4 and -9.1Kcal〖mol〗^(-1) in 3n7r and 6e59 respectively. All the other compounds also showed low binding scores indicating that the plant may be a drug lead candidate for the control of migraine headache. The density functional theory results revealed that the plant would be biologically stable. The results obtained from this research validate the local claim that Zingiber officinale is effective in the treatment of migraine headache.

Keywords

EN

calcitonin gene-related peptide (CGRP); human NK1 tachykinin; migraine; molecular docking; zingiber officinale

Discipline

• CHEMISTRY: CHEMISTRY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2024
• Volume: 55
• Pages: 184-205

Contributors

author

Adindu Chinonso Blessing

• Department of Chemistry, Imo State University, Owerri, P M B 2000 Owerri, Imo State, Nigeria

author

Kalu Georgiana Ijeoma

• Department of Chemistry, Imo State University, Owerri, P M B 2000 Owerri, Imo State, Nigeria

References

• [1] Andreou A P, Edvinsson L, Mechanisms of migraine as a chronic evaluative condition. Journal of Headache and Pains. 2019; 117(20) https://doi.org/10.1186/s10194-019-1066-0
• [2] Johra K L, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomedicine & Pharmacotherapy. 2021; 139, 111557
• [3] Mungoven T J, Henderson LA, Meylakh N, Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives. Frontiers in Pains Research., 2021; 2, 705276 .doi: 10.3389/fpain.2021.705276
• [4] Ples H. Florian I A, Timis T L, Covache-Busuioc R A, Glavan L A, Dumitrascu D I, Popa A A, Bordeianu A, Ciurea A V, Migraine, Advances in the Pathogenesis and Treatment. Neurology. International. 2023; 15, 1052–1105. https://doi.org/10.3390/neurolint15030067
• [5] Kamm K, CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far? Frontiers in Neurology. 2022; 13, 930383. doi: 10.3389/fneur.2022.930383
• [6] Kamm K, Straube A, Ruscheweyh R. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia. 2019;39(12):1535-1543. doi:10.1177/0333102419856640
• [7] Wattiez A S, Sowers L P, Russo A F, Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opinion on Therapeutic Targets. 2020; (2): 91-100. doi: 10.1080/14728222.2020.1724285
• [8] Kee Z, Kodji X, Brain S D, The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects. Frontier in. Physiology. 2018; 9: 1249. doi: 10.3389/fphys.2018.01249
• [9] Maggio R, Fasciani I, Carli M, Petragnano F, Marampon F, Rossi M, Scarselli M. Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers. Biomolecules. 2021; 11(12): 1828. doi: 10.3390/biom11121828
• [10] Yuyan H, Shannon G, Fanyin M, Heather Francis, Marco M, Kelly M, Domenico A, Julie V, Guido C, Paolo O, Eugenio G, Gianfranco A, Antonio F, Recent advances in the morphological and functional heterogeneity of the biliary epithelium, Experimental Biology and Medicine 2013; 238: 549–565. DOI: 10.1177/1535370213489926
• [11] Durham P L, Vause C V, Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs. 2010; 24(7): 539-48. doi: 10.2165/11534920-000000000-00000
• [12] Deen M, Correnti E, Kamm K, et al. Blocking CGRP in migraine patients – a review of pros and cons. Journal of Headache and Pains 2017; 18, 96 https://doi.org/10.1186/s10194-017-0807-1
• [13] Shahrajabian M H, Sun W, Cheng Q, Clinical aspects and health benefits of ginger (Zingiber officinale) in both traditional Chinese medicine and modern industry. Acta Agriculturae Scandinavica, Section B — Soil & Plant Science. 2019; 69(6), 546–556. https://doi.org/10.1080/09064710.2019.1606930
• [14] Chinedu I, Jivini S Z, Medicinal Properties of Ginger and Garlic: A Review, Review Article, Current Trends in Biomedical Engineering & Biosciences, 2019; 18 (2). DOI: 10.19080/CTBEB.2019.18.555985
• [15] Nunes C P, Rodrigues C C, Cardoso C A F, Cytrynbaum N, Kaufman R, Rzetelna H, Goldwasser G, Santos A, Oliveira L, Geller M. Clinical Evaluation of the Use of Ginger Extract in the Preventive Management of Motion Sickness. Current Therapeutic Research, Clinical and Experimental. 2020; 92: 100591. doi: 10.1016/j.curtheres.2020.100591
• [16] Najim A. Jabir Al-Awwadi, Potential health benefits and scientific review of ginger, journal of Pharmacognosy and Phytotherapy, 2017; 9(7), 111-116, DOI: 10.5897/JPP2017.0459.
• [17] Kim H, Park K T, Jo H, Shin Y, Chung G, Ko S G, Jin Y H, Kim W, The effect of ginger extract on cisplatin-induced acute anorexia in rats. Fronier. Pharmacology. 2023; 14: 1267254
• [18] Aggarwa M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci. National library of medicine. 2012; (2): 88-94. doi: 10.5214/ans.0972.7531.12190210.
• [19] Ashmita G, Bhushan K, Babita K, Shradha P, Sabuj K M, Uday N Y, Effectiveness of Zingiber Officinale (ginger) compared with non-steroidal anti-inflammatory drugs and complementary therapy in primary dysmenorrhoea: A systematic review. Clinical Epidemiology and Global Health. 2022; 18: 101152, https://doi.org/10.1016/j.cegh.2022.101152
• [20] Adindu C B, Oguzie E E, Investigating the extract constituents and corrosion inhibiting ability of Sida acuta leaves, WNOFNS 2017; 13: 63-81
• [21] Duru C E, Duru A I, Adegboyega A E, In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets. Bulletine National Research Centre. 2021; 45:57 https://doi.org/10.1186/s42269-021-00517-x.
• [22] Ter H E, Koth C M, Abdul-Manan N, Swenson L, Coll J T, Lippke J A, Lepre C A, Garcia-Guzman M, Moore J M. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure. National library of medicine. 2010; 18(9): 1083-93. doi: 10.1016/j.str.2010.05.014
• [23] Yin J, Chapman K, Clark L D, Shao Z, Borek D, Xu Q, Wang J, Rosenbaum DM. Crystal structure of the human NK1 tachykinin receptor. The Proceedings of the National Academy of Sciences (PNAS) 2018; 115(52): 13264-13269. doi: 10.1073/pnas.1812717115
• [24] Mun CS, Hui LY, Sing LC, Karunakaran R, Ravichandran V. Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19. Saudi Journal of Biological Sciences. 2022;(12):103458. doi: 10.1016/j.sjbs.2022.103458
• [25] Bitew M, Desalegn T, Demissie TB, Belayneh A, Endale M, Eswaramoorthy R. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study. PLoS One. 2021; 16(12): e0260853. doi: 10.1371/journal.pone.0260853
• [26] E. E. Oguzie, C. B. Adindu, C. K. Enenebeaku, C. E. Ogukwe, M. A. Chidiebere, K. L. Oguzie, Journal of Physical Chemistry. 2012; 116 (1) 3603-13615.
• [27] Iwu I C, Oze R N, Onu U L, Amarachi N, Ukaoma A, phytochemical and GC-MS analysis of the rhizome of Zingiber officinale plant grown in eastern part of Nigeria. African Journal of Biology and Medical Research. 2018; 11, 43
• [28] Van der Schueren BJ, Blanchard R, Murphy MG, Palcza J, De Lepeleire I, Van Hecken A, Depré M, de Hoon JN. The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men. British Journal of Clinnical Pharmacolgy. 2011; 71(5): 708-17. doi: 10.1111/j.1365-2125.2010.03869.x
• [29] Oguzie E E Ogukwe C E Ogbulie J N Nwanebu F C Adindu C B Udeze I O Oguzie K L Eze F C Broad spectrum corrosion inhibition: corrosion and microbial (SRB) growth inhibiting effects of Piper guineense extract, Journal of Material Science. 2012 (47) 3592–3601
• [30] Shaaban S, Abdou A, Alhamzani AG, Abou-Krisha MM, Al-Qudah MA, Alaasar M, Youssef I, Yousef TA. Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential Mpro Inhibitors for the SARS-CoV-2. Replication. Life (Basel). 2023; 13(4): 912. doi: 10.3390/life13040912

• Document Type: article